Trial Profile
The Effect of Oseltamivir Treatment on the Yield of Polymerase Chain Reaction Test for Confirmed Influenza Infection Among Adults - a Prospective, Cohort Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2017
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 29 Sep 2017 Status changed from recruiting to completed.
- 24 Sep 2015 Planned End Date changed from 1 May 2015 to 1 Sep 2017, as reported by ClinicalTrials.gov.
- 24 Sep 2015 Planned primary completion date changed from 1 May 2015 to 1 May 2017, as reported by ClinicalTrials.gov.